REDWOOD CITY, Calif., May 2 /PRNewswire/ -- Ingenuity Systems, the leading provider of solutions for the exploration, interpretation, and analysis of life science information, today announced that it has entered an agreement with Wyeth to extend and expand its licensing agreement for access to IPA software. Wyeth's research and development teams will utilize IPA in multiple research areas, including its pharmacogenomics group that focuses on novel approaches to identifying biomarkers.
"We are pleased that Wyeth has selected Ingenuity Systems as a key partner for its research programs," said Peter DiLaura, Senior Vice President of Commercial Operations at Ingenuity. "Wyeth has been a valued customer since 2003, and we view this renewal as a testament to our ability to provide relevant and valuable solutions for researchers who need to analyze and understand the biological and chemical relationships within their experimental systems."
IPA is a software and content solution that provides unique insights and understanding of complex biological and chemical systems at the core of life science research. IPA is deployed in all major pharmaceutical companies and in hundreds of biotechnology companies and academic institutions globally. It supports analysis of data from all experimental platforms and is used at all stages of the drug discovery and development process, including target identification and validation, identification of biomarkers, predictive toxicology, and pharmacogenomics.
Trials of Ingenuity Pathways Analysis 5.0 are currently being offered at http://www.ingenuity.com/trial. For more information about Ingenuity Pathways Analysis 5.0, please email sales@ingenuity.com or go to www.ingenuity.com.
About Ingenuity Systems(R)
Ingenuity enables researchers to model, analyze, and understand complex biological and chemical systems foundational to human health and disease. The Ingenuity products include pathways analysis software and knowledge bases for life scientists and bioinformaticians, and enterprise knowledge management infrastructure, content and services for leading pharmaceutical and biotech companies. Ingenuity was founded in 1998 and is headquartered in Redwood City, California, with offices in Germany, Switzerland, France, the United Kingdom, and Japan. www.ingenuity.com.
Ingenuity SystemsCONTACT: Heidi Bullock, Director, Marketing of Ingenuity Systems,+1-650-381-5150
Web site: http://www.ingenuity.com//
